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cetamolAbstract Complexes of Mg(II), Ca(II), Ba(II) and Sr(II) with paracetamol drug were synthesized
and characterized by elemental analysis, conductivity, UV–Vis, IR, and 1H NMR spectroscopy and
thermal analysis, as well as screened for antimicrobial activity. The IR spectral data suggested that
the ligand behaves as paracetamol behaves as a neutral bidentate ligand coordinated to the metal
ions via the lone pair of electrons of nitrogen and carbonyl-O atoms of the amide group. From
the microanalytical data, the stoichiometry of the complexes reacts with Mg(II), Ca(II), Ba(II)
and Sr(II) by molar ratios (2:1) (paracetamol:metal ion). The thermal behavior (TG/DTG) of the
complexes was studied. The ligand and their metal complexes were screened against both of anti-
bacterial and fungicidal activities.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.ent of Chemistry, Faculty of
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An analgesic (also known as a painkiller) is any member of the
group of drugs used to relieve pain (achieve analgesia). The
word analgesic derives from Greek an- (‘‘without’’) and algos
(‘‘pain’’). Analgesic drugs act in various ways on the peripheral
and central nervous systems. They include paracetamol
(para-acetylaminophenol, also known in the US as acetamino-
phen), the non-steroidal anti-inﬂammatory drugs (NSAIDs)
such as the salicylates, narcotic drugs such as morphine,
synthetic drugs with narcotic properties such as tramadol. In
choosing analgesics, the severity and response to othering Saud University.
nd thermal degradation behavior of Mg(II), Ca(II), Ba(II) and
mistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.08.017
2 M.S. Refat et al.medication determines the choice of the agent; the WHO pain
ladder, originally developed in cancer-related pain, is widely
applied to ﬁnd suitable drugs in a stepwise manner (World
Health Organization, 1990). The analgesic choice is also deter-
mined by the type of pain. For neuropathic pain, traditional
analgesics are less effective, and there is often beneﬁt from clas-
ses of drugs that are not normally considered analgesics, such
as tricyclic antidepressants and anticonvulsants (Dworkin
et al., 2003).
Paracetamol or acetaminophen is a widely used over-the-
counter analgesic (pain reliever) and antipyretic (fever reducer)
(see Fig. 1). It is commonly used for the relief of fever, head-
aches, and other minor aches and pains, and is a major ingre-
dient in numerous cold and ﬂu remedies. In combination with
non-steroidal anti-inﬂammatory drugs (NSAIDs) and opioid
analgesics, paracetamol is used also in the management of
more severe pain (such as postoperative pain).
While generally safe for human use at recommended doses
(1000 mg per single dose and up to 4000 mg/day for adults, up
to 2000 mg/day if drinking alcohol (www.drug.com/acetami-
nophen.html), acute overdoses of paracetamol can cause
potentially fatal liver damage and, in rare individuals, a nor-
mal dose can do the same; the risk is heightened by alcohol
consumption. Paracetamol toxicity is the foremost cause of
acute liver failure in the Western world, and accounts for most
drug overdoses in the United States, the United Kingdom,
Australia and New Zealand (Daly et al., 2008; Khashab
et al., 2007; Hawkins and Edwards, 2007).
Paracetamol is derived from coal tar, and is part of the class
of drugs known as ‘‘aniline analgesics’’; it is the only such drug
still in use today (Bertolini et al., 2006). It is the active metab-
olite of phenacetin, once popular as an analgesic and antipy-
retic in its own right, but unlike phenacetin and its
combinations, paracetamol is not considered to be carcino-
genic at therapeutic doses (Bergman et al., 1996). The words
acetaminophen (used in the United States, Canada and Hong
Kong) and paracetamol (used elsewhere) both come from
chemical names for the compound: para-acetylaminophenol.
In some contexts, it is simply abbreviated as APAP, for
N-acetyl-para-aminophenol.
Acetanilide was the ﬁrst aniline derivative serendipitously
found to possess analgesic as well as antipyretic properties,
and was quickly introduced into medical practice under the
name of Antifebrin by Cahn and Hepp (1886). But its unac-
ceptable toxic effects, the most alarming being cyanosis due
to methemoglobinemia, prompted the search for less toxicFigure 1 Structure of paracetamol or acetaminophen.
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synthesized paracetamol at Johns Hopkins University via the
reduction of p-nitrophenol with tin in glacial acetic acid in
1877 (Morse, 1878; Silverman et al., 1992), but it was not until
1887 that clinical pharmacologist Joseph von Mering tried
paracetamol on patients. In 1893, von Mering published a
paper reporting on the clinical results of paracetamol with
phenacetin, another aniline derivative (Von Mering, 1893).
Von Mering claimed that, unlike phenacetin, paracetamol
had a slight tendency to produce methemoglobinemia. Para-
cetamol was then quickly discarded in favor of phenacetin.
The sales of phenacetin established Bayer as a leading pharma-
ceutical company. Overshadowed in part by aspirin, intro-
duced into medicine by Heinrich Dreser in 1899, phenacetin
was popular for many decades, particularly in widely
advertised over-the-counter ‘‘headache mixtures,’’ usually
containing phenacetin, an aminopyrine derivative or aspirin,
caffeine, and sometimes a barbiturate.
Paracetamol consists of a benzene ring core, substituted by
one hydroxyl group and the nitrogen atom of an amide group
in the para (Bales et al., 1985). The amide group is acetamide
(ethanamide). It is an extensively conjugated system, as the
lone pair on the hydroxyl oxygen, the benzene pi cloud, the
nitrogen lone pair, the p-orbital on the carbonyl carbon, and
the lone pair on the carbonyl oxygen are all conjugated. The
presence of two activating groups also makes the benzene ring
highly reactive toward electrophilic aromatic substitution. As
the substituents are ortho, para-directing and para with respect
to each other, all positions on the ring are more or less equally
activated. The conjugation also greatly reduces the basicity of
the oxygens and the nitrogen, while making the hydroxyl
acidic through delocalisation of charge developed on the phen-
oxide anion.
Paracetamol is usually classiﬁed along with nonsteroidal
antiinﬂammatory drugs (NSAID), but is not considered one.
Like all drugs of this class, its main mechanism of action is
the inhibition of cyclooxygenase (COX), an enzyme responsi-
ble for the production of prostaglandins, which are important
mediators of inﬂammation, pain and fever. Therefore, all
NSAIDs are said to possess anti-inﬂammatory, analgesic
(anti-pain), and antipyretic (anti-fever) properties. The speciﬁc
actions of each NSAID drug depend upon their pharmacolog-
ical properties, distribution and metabolism (Ottani et al.,
2006).
Complexes of paracetamol with various metal ions such as,
Cu(II), Zn(II) or Fe(II) ions of ratio 2:1, respectively, have
been prepared and their structure has been conﬁrmed by ele-
mental analysis, atomic absorption spectra, IR spectra and
1H NMR spectra and ﬁnally it can be concluded that the struc-
ture of the complexes has C2h point group symmetry in which
two PA molecules are chelated to any one of the metal ions,
Cu(II), Zn(II) and Fe(II) ions (El-Shahawy et al., 2007).
The kinetics of the oxidation of ruthenium(III)- and os-
mium(VIII)-catalyzed oxidation of paracetamol by diperiodat-
oargentate(III) (DPA) in aqueous alkaline medium at a
constant ionic strength of 0.10 mol dm3 was studied spectro-
photometrically (Sirsalmath et al., 2006). The reaction between
DPA and paracetamol in alkaline medium exhibits 2:1 stoichi-
ometry in both catalyzed reactions (DPA:PAM). The main
products were identiﬁed by spot test, IR, NMR and
GC–MS. Probable mechanisms are proposed and discussed.
The activation parameters with respect to the slow step ofnd thermal degradation behavior of Mg(II), Ca(II), Ba(II) and
mistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.08.017
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namic quantities are also calculated. It has been observed that
the catalytic efﬁciency for the present reaction is in the order of
Os(VIII) > Ru(III). The active species of catalyst and oxidant
has been identiﬁed.
The comparative study of Ru(III)- and Os(VIII)-catalyzed
oxidation of paracetamol by diperiodatoargentate(III) was
studied. Oxidation products were identiﬁed. Among various
species of Ag(III) in alkaline medium, monoperiodatoargen-
tate(III) is considered to be the active species for the title reac-
tion. The active species of Ru(III) is found to be
[Ru(H2O)5OH]
2+ and that for Os(VIII) is [OsO4(OH)2]
2.
Activation parameters were evaluated for both catalyzed and
uncatalyzed reactions. Catalytic constants and the activation
parameters with reference to the catalyst were also computed.
The catalytic efﬁciency is Ru(III) < Os(VIII).
Elena V. Boldyreva summarized experimental X-ray dif-
fraction and IR-spectroscopic data on the effect of pressure
on a number of molecular and ionic-molecular crystals: mono-
clinic (I) and orthorhombic (II) polymorphs of paracetamol,
fenacetin, monoclinic (a) and trigonal (g) polymorphs of gly-
cine, p-benzoquinone, Co(III)-nitro- and nitrito-pentaammine
complexes, and sodium oxalate (Boldyreva, 2003). Special
attention is paid to the role of intermolecular interactions, in
particular hydrogen bonds, in the anisotropy of structural dis-
tortion. For several compounds, the distortions induced by
high-pressure and low-temperature are compared.
Pressure-induced polymorphic transitions attract much
more attention than continuous structural changes in the same
polymorph. However, the latter can also be valuable not only
to predict the direction of a polymorphic transformation and
to understand its mechanism but also to ﬁnd parameters char-
acterizing intermolecular interactions in crystals, in particular
hydrogen bonds of various types (Boldyreva, 2003). This infor-
mation can ﬁnd various applications, ranging from crystal
engineering, polymorph prediction and solid-state reactivity
to the prediction of secondary and ternary structures of bio-
polymers and their response to various external actions.
It was found that polyvinylpyrrolidone (PVP) is an effective
additive during crystallization of paracetamol and signiﬁcantly
inﬂuenced the crystallization and crystal habit of paracetamol
(Garekani et al., 2000). These effects were attributed to
adsorption of PVP onto the surfaces of growing crystals. It
was found that the higher molecular weights of PVP (PVP
10,000 and PVP 50,000) were more effective additives than
lower molecular weight PVP (PVP 2000). Paracetamol parti-
cles obtained in the presence of 0.5% w/v of PVP 10,000 or
PVP 50,000 had near spherical structure and consisted of
numerous rod-shaped microcrystals which had agglomerated
together. Particles obtained in the presence of PVP 2000 con-
sisted of fewer microcrystals. Differential scanning calorimetry
(DSC) and X-ray powder diffraction (XPD) experiments
showed that paracetamol particles, crystallized in the presence
of PVP, did not undergo structural modiﬁcations. By increas-
ing the molecular weight and/or the concentration of PVP in
the crystallization medium the amount of PVP incorporated
into the paracetamol particles increased. The maximum
amount of PVP in the particles was 4.32% w/w.
After a large drug scanning (Alapont et al., 1999), the sys-
tem Luminol–H2O2–FðCNÞ36 is proposed for ﬁrst time for the
indirect determination of paracetamol. The method is based on
the oxidation of paracetamol by hexacyanoferrate (III) and thePlease cite this article in press as: Refat, M.S. et al., Spectroscopic a
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and hydrogen peroxide. The procedure resulted in a linear cal-
ibration graph over the range 2.5–12.5 mg ml1 of paraceta-
mol with a sample throughput of 87 samples/h. The
inﬂuence of foreign compounds was studied and, the method
was applied to the determination of the drug in three different
pharmaceutical formulations.
The goal of this paper is to get a wide understanding of the
structural and spectral properties as well as microbial activities
of paracetamol and their Mg(II), Ca(II), Ba(II) and Sr(II) me-
tal ion complexes. Metallo-ibuprofen complexes were investi-
gated by spectral and thermal techniques.
2. Experimental
2.1. Chemicals
All chemicals used were of the purest laboratory grade
(Merck). Selected metal-salts like MgCl2, CaCl2, BaCl2Æ2H2O,
and SrCl2Æ7H2O were used. Paracetamol was received from
Egyptian international pharmaceutical industrial company
(EIPICO).
2.2. Synthesis of Para complexes
The above complexes were prepared, employing a 1:2 (metal
ions:para) ratio. A solution of 0.5 mmol of a salt of each
Mg(II), Ca(II), Ba(II) and Sr(II) dissolved in 10 ml of distilled
water was added to a solution of 1.0 mmol of paracetamol in
20 ml of methyl alcohol under magnetic stirring. The pH of
each solution adjusted at pH 7 using 5% alcoholic ammonia
solution. The resulting solutions stirred and reﬂuxed on a
hot plate at 50 C for 1 h and left to evaporate slowly at room
temperature. One day later, the obtained precipitates were ﬁl-
tered off, washed with hot water then dried at 60 C.
2.3. Preparation of stock solutions
2.3.1. Sodium chloride solution
A standard solution of 0.01 M sodium chloride is prepared by
dissolving 0.0584 g of NaCl in a small amount of distilled
water then completed to 100 ml in a measuring ﬂask.
2.3.2. Barium chloride solution
A 10 g of barium chloride dihydrate, BaCl2Æ2H2O, was
weighed and dissolved in the least amount of distilled water.
The volume was completed to 100 ml in a measuring ﬂask to
give 10% solution.
2.3.3. Silver nitrate solution
A weight of 0.1701 g of AgNO3 was dissolved in a small
amount of distilled water then completed to 100 ml in a dark
measuring ﬂask to obtain an approximate 0.01 M solution.
The concentration of AgNO3 solution was checked by the
titration against 0.01 M NaCl solution and the exact concen-
tration was found to be 0.01004 M.
2.3.4. Ammonium hydroxide solution
The stock solution of NH4OH was prepared by taking
15.15 ml of the concentrated NH3 (33%) in 35 ml distillednd thermal degradation behavior of Mg(II), Ca(II), Ba(II) and
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4 M.S. Refat et al.water. The volume was then completed to 100 ml by methanol
to give approximately 5% solution.
2.3.5. Complex solution
An accurate weight of 0.2 g from the solid complex in each
case was dissolved in the least amount of 2 M nitric acid.
The solution evaporated near to dryness. This process repeated
twice and the residue dissolved in about 50 ml of hot distilled
water to obtain a clear solution. The volume then completed to
100 ml in a measuring ﬂask.
2.4. Apparatus and experimental conditions
2.4.1. Micro analytical techniques
Carbon, hydrogen and nitrogen contents were determined
using a perkin–Elmer CHN 2400. The metal content was found
gravimetrically by converting the compounds into their corre-
sponding carbides or oxides. The Mg(II), Ca(II), Ba(II) and
Sr(II) contents were determined gravimetrically by the direct
ignition of the complexes at 1000 C for 3 h till constant weight.
The residue was then weighed in the forms of metal oxides.
2.4.2. Molar conductance
Molar conductivities of freshly prepared 1.0 · 103 mol/L
DMSO solutions of the complexes were measured using Jen-
way 4010 conductivity meter.
2.4.3. Infrared spectra
IR spectra were recorded on Bru¨ker FTIR Spectrophotometer
(4000–400 cm1) in KBr pellets.
2.4.4. Electronic spectra
The UV–Vis spectra were determined in the DMSO solvent
with concentration (1.0 · 103 M) for the free ligands and their
complexes using Jenway 6405 spectrophotometer with 1 cm
quartz cell, in the range 200–800 nm.
The solid reﬂectance spectra were performed on a Shima-
dzu 3101 pc spectrophotometer.
2.4.5. 1H NMR spectra
1H NMR spectra of the free ligands and their complexes were
recorded on varian Gemini 200 MHZ spectrophotometer using
DMSO-d6 as solvent and TMS as an internal reference.
2.4.6. Thermal analysis (TG and DTG) techniques
Thermogravimetric analysis (TG and DTG) was carried out in
the temperature range from 25 to 800 C in a steam of nitrogenTable 1 Elemental analyses and physical data of para and its Mg(




396.3 47.97 48.48 6.43
[Ca(para)2(OH)2]Æ6H2O
C16H32CaN2O12
484.1 39.19 39.67 6.49
[Ba(para)2(OH)2]Æ2H2O
C16H24BaN2O8
509.3 37.09 37.7 4.16
[Sr(para)2(OH)2]Æ2H2O
C16H24SrN2O8
459.6 41.13 41.78 5.45
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imental conditions were: platinum crucible, nitrogen atmo-
sphere with a 30 ml/min ﬂow rate and a heating rate 10 C/min.
2.5. Microbiological investigation
2.5.1. Hole well method
The investigated isolates of bacteria and fungi were seeded in
tubes with nutrient broth (NB) and Dox’s broth (DB), respec-
tively. The seeded (NB) for bacteria and (DB) for fungi (1 ml)
were homogenized in the tubeswith 9 ml ofmelted (45 C) nutri-
ent agar (NA) for bacteria and (DA) for fungi. The homogenous
suspensions were poured into Petri dishes. The holes (diameter
0.5 cm) were done in the cool medium. After cooling in these
holes, 100 l of the investigated compounds was applied using a
micropipette. After incubation for 24 h in an incubator at 37
and 28 C for bacteria and fungi, respectively, the inhibition
zone diameters were measured and expressed in cm. The antimi-
crobial activities of the investigated compounds were tested
against Escherichia coli and Pseudomonas aeruginosa as (Gram
ve) and Bacillus subtilis and Bacillus cereus as (Gram +ve)
bacteria as well as some kinds of fungi; Aspergillus ﬂavus and
Aspergillus niger. In the same time with the antimicrobial inves-
tigations of the complexes, the pure solvent was also tested. The
concentration of each solution was 1.0 · 103 mol/L. Commer-
cial DMSO was employed to dissolve the tested samples.
3. Results and discussion
3.1. Paracetamol complexes
3.1.1. Molar conductivities of metal chelates of paracetamol
The molar conductance values for the Mg(II), Ca(II), Ba(II)
and Sr(II) complexes of para in DMSO solvent
(1.00 · 103 M) were found to be in the range 57.40–
72.80 1 cm2 mol1 at 25 C, suggesting them to be non-elec-
trolytes Table 1. These data matched with the calculated ele-
mental analysis that Cl ions were not detected by the
addition of AgNO3 solution to the solutions of the mentioned
complexes in nitric acid. The above complexes are air-stable,
with higher melting points, insoluble in H2O, partially soluble
in ethanol and methanol and most of organic solvents except
for DMSO, DMF and concentrated acids are soluble.
3.1.2. Infrared spectra of Mg(II), Ca(II), Ba(II) and Sr(II)
complexes of paracetamol
The IR data of paracetamol and its complexes are listed in Ta-
ble 2 and shown in Figs. 2–5. From the comparative IR spectraII), Ca(II), Ba(II) and Sr(II) compelxes.
%N %M K (X1 cm2 mol1)
Calcd. Found Calcd. Found Calcd.
6.06 7.45 7.07 6.12 6.06 72.6
6.61 5.29 5.79 8.41 8.26 63.8
4.71 5.25 5.5 26.78 26.96 72.8
5.22 6.61 6.09 19.15 19.06 57.4
nd thermal degradation behavior of Mg(II), Ca(II), Ba(II) and
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Table 2 IR frequencies (4000–400 cm1) of para and its Mg(II), Ca(II), Ba(II) and Sr(II) complexes.
Compound m(NH) and m(OH) m(C‚O) d(CNH); amide group m(C–O); phenyl group m(M–N) m(M–O)
Paracetamol 3300s 1640vs 1540sh 1256vs – –
[Mg(para)2(OH)2]Æ2H2O 3410br 1646sh 1566s 1252w 469w 509w
[Ca(para)2(OH)2]Æ6H2O 3427br 1647sh 1564s 1252w 465w 511s
[Ba(para)2(OH)2]Æ2H2O 3206w, 3325s, 3459s 1651m 1563sh 1251w 413s 567s, 512 m
[Sr(para)2(OH)2]Æ2H2O 3325s 1653m 1562sh 1253s 417s 507sh
s, small, sh, sharp, m, medium, w, weak, br, broad.
Figure 2 FTIR spectrum of Mg(II) complex of paracetamol.
Figure 3 FTIR spectrum of Ca(II) complex of paracetamol.
Spectroscopic and thermal degradation behavior of Mg(II), Ca(II), Ba(II) and Sr(II) complexes 5of paracetamol and its complexes, a slight blue shift of the
stretching band of the carebonyl group, (C‚O) of paraceta-
mol which is found at 1640 cm1 from 1646 to 1653 cm1 in
the complexes spectra has been noticed. Also, a slight shiftPlease cite this article in press as: Refat, M.S. et al., Spectroscopic a
Sr(II) complexes with paracetamol drug. Arabian Journal of Cheof the in-plane bending band of the carbonyl group of the par-
acetamol spectrum at 840–830 cm1 in the complex spectra
and the disappearance of the in-plane bending bands of
CNH at positions 1540 and 1260 cm1 in the IR spectra ofnd thermal degradation behavior of Mg(II), Ca(II), Ba(II) and
mistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.08.017
Figure 4 FTIR spectrum of Ba(II) complex of paracetamol.
Figure 5 FTIR spectrum of Sr(II) complex of paracetamol.
Table 3 1H NMR spectral data of para and its Ba(II) complex.
Compound dppm of hydrogen
H; CH3 H; H2O H; ArH H; NH
Paracetamol 1.96 – 6.57–7.28 9.27
Ba(II) complex 1.97 3.39 6.66–7.36 9.83
6 M.S. Refat et al.the complexes in addition to the appearance and disappear-
ance of the stretching band and the out-of-plane wagging band
of NH in the amide group in the complex spectra have been
noticed (Nakamato and Mc Carthy, 1968). On the basis of
the above observations, we concluded that the coordination
mode proceeds via the participation of the carbonyl-O andPlease cite this article in press as: Refat, M.S. et al., Spectroscopic a
Sr(II) complexes with paracetamol drug. Arabian Journal of CheNH atoms of the amide group. The appearance of the stretch-
ing band and the in-plane bending band of the hydroxyl group,
with respect to the phenyl moiety at positions around 1256 and
620 cm1, respectively, excludes the contribution of the hydro-
xyl oxygen atom to be chelated with the metal ion as well as
the appearance of the stretching band in the hydroxyl groupnd thermal degradation behavior of Mg(II), Ca(II), Ba(II) and
mistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.08.017
Figure 6 1H NMR spectrum of Ba(II) complex of paracetamol.











Figure 7 Electronic absorption spectrum of Mg(II) complex of paracetamol.
















Figure 8 Electronic absorption spectrum of Ca(II) complex of
paracetamol.
Spectroscopic and thermal degradation behavior of Mg(II), Ca(II), Ba(II) and Sr(II) complexes 7between oxygen and hydrogen atom at position 3300 cm1 ver-
iﬁes the assumption of the exclusion of the hydroxyl oxygen
atom to be chelated with the metal ion in the complex
(Nakamoto, 1997).
3.1.3. 1H NMR of paracetamol and its Ba(II) complex
The 1H NMR data of para and its Ba(II) complex, as an exam-
ple are listed in Table 3 and shown in Fig. 6. The 1H NMRPlease cite this article in press as: Refat, M.S. et al., Spectroscopic a
Sr(II) complexes with paracetamol drug. Arabian Journal of Chespectrum of paracetamol shows the signals at d= 9.27 ppm,
which are assigned to the protons of the amide group and
the appearance of a large systematic shift of this signal of
the amide hydrogen atom at d= 9.83 ppm in the 1H NMR
spectrum of Ba(II) complex of paracetamol conﬁrms the par-
ticipation of the amide nitrogen atom in the complexation be-
tween para and M(II) ion. The persistence of the signal of the
proton of the hydroxyl group in the 1H NMR spectrum of the
complex conﬁrms that the hydroxyl group does not contribute
in the complexation between para and M(II) ion therefore, the
hydroxyl group is still free in the complex of paracetamol. So,
the complexation between two molecules of paracetamol with
M(II) ion has been formed by the chelation of the metal ion
with the carbonyl-O and the amide-N atoms containing the
amide hydrogen atoms to form the complex (para)2-M includ-
ing the nitrogen metal (Trinchero et al., 2004).
3.1.4. Electronic absorption spectra of paracetamol complexes
The formation of the Mg(II), Ca(II), Ba(II) and Sr(II) com-
plexes of paracetamol was also conﬁrmed by UV–Vis spectra.
Figs. 7–10 show the electronic absorption spectra of the M(II)
complexes in DMSO in the 200–600 nm range. It can be seen
that free paracetamol has two distinct absorption bands. The
ﬁrst one at 300 nm may be attributed to pﬁ p* intra-ligand
transition of the aromatic ring. The second band observed at
390 nm is attributed to nﬁ p* electronic transition. In the
spectra of the M(II) complexes, the two bands are hypsochro-
mically affected clearly, suggesting the ligand is not deproto-
nated, but the lone pair of electrons on nitrogen and
carbonyl-oxygen atoms of the amide group is participated innd thermal degradation behavior of Mg(II), Ca(II), Ba(II) and
mistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.08.017














Figure 9 Electronic absorption spectrum of Ba(II) complex of paracetamol.































Figure 10 Electronic absorption spectrum of Sr(II) complex of paracetamol.
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[Mg(para)2(OH)2]Æ2H2O 35–135 51, 123 2 23.01 (23.23) 16.32 (16.16) Loss of 2(H2O) and 2(CO) MgO+ 2C
135–425 258, 356 2 28.36 (28.28) Loss of 2(NO) and 2(C2H2)
425–695 537, 668 2 32.31 (32.33) Loss of 4(C2H2), 1/2O2 and 4H2
[Ca(para)2(OH)2]Æ6H2O 20–130 53, 110 2 22.03 (22.31) 26.90 (26.45) Loss of 6(H2O) CaO+ 6C
135–315 266 1 33.02 (33.06) Loss of 2(OH), 2(CO), C2H2, NO and 1/2N2
315–625 358, 512 2 18.05 (18.18) Loss of 3(C2H2) and 5H2
[Ba(para)2(OH)2]Æ2H2O 50–135 72, 107 2 6.80 (7.07) 34.58 (34.81) Loss of 2(H2O). BaO + 2C
135–490 266, 377 2 58.62 (58.12) Loss of 2(OH), C6H6, 2(CO), C6H6O and 2(NH3)
[Sr(para)2(OH)2]Æ2H2O 35–175 49, 93, 138 3 8.31 (7.83) 38.39 (38.21) Loss of 2(H2O) SrO + 6C
175–300 264 1 45.68 (46.13) Loss of 2(H2O),C6H6O,C2H2 and 2(CO)
300–605 306, 362 2 7.62 (7.83) Loss of 2(NH3) and H2
a n, number of decomposition steps.
Figure 11 TG/DTG curve of Mg(II) complex of paracetamol.
Spectroscopic and thermal degradation behavior of Mg(II), Ca(II), Ba(II) and Sr(II) complexes 9the complexation. These results are clearly in accordance with
the results of the FTIR and 1H NMR spectra.
3.1.5. Thermal analysis of para and its Mg(II), Ca(II), Ba(II)
and Sr(II) complexes
The heating rates were controlled at 10 C/min under nitrogen
atmosphere and the weight loss was measured from ambient
temperature up to @1000 C. The data are listed in Table 4
and shown in Figs. 11–14. The weight losses for each chelate
were calculated within the corresponding temperature ranges.
3.1.5.1. [Mg(para)2(OH)2]Æ2H2O. The thermal decomposi-
tion of [Mg(para)2(OH)2]Æ2H2O complex occurs at six steps.
The ﬁrst and second degradation steps take place in the range
of 35–135 C and they correspond to the elimination of 2(H2O)
and 2(CO) molecules with an observed weight loss of 23.01%
(calcd. = 23.23%). The third and fourth steps fall in the range
of 135–425 C which are assigned to the loss of 2(NO) and 2
(C2H2) molecules with a weight loss (obs. = 28.36%,
calcd. = 28.28%). The ﬁfth and sixth decomposition steps
within the temperature range 425–695 C were accompanied
by a mass loss of 32.31% (calcd. = 32.33%), which are as-
signed to the loss of 4(C2H2), 1/2O2 and 4(H2) molecules.Please cite this article in press as: Refat, M.S. et al., Spectroscopic a
Sr(II) complexes with paracetamol drug. Arabian Journal of CheThe MgO and 2C are the ﬁnal products remaining stable till
800 C.
3.1.5.2. [Ca(para)2(OH)2]Æ6H2O. The calcium (II) paraceta-
mol complex is decomposed in ﬁve steps. The ﬁrst and second
steps are exhibited at 20–130 C and corresponding to the loss
of 6(H2O) molecules, representing a weight loss of
(obs. = 22.03%, calcd. = 22.31%). The third step takes place
within the temperature range 130–315 C and can be assigned
to the loss of 2(OH), 2(CO), C2H2, NO and 1/2N2 molecules
and the mass loss due to this step was (obs. = 33.02%,
calcd. = 33.06%). The last two steps are occurring at 315–
625 C and corresponding to the evolution of 3(C2H2) and
5H2 gases, representing a weight loss of 18.05% and its calcu-
lated value is 18.18%. The ﬁnal products resulted at 800 C
contain CaO polluted with six carbon atoms.
3.1.5.3. [Ba(para)2(OH)2]Æ2H2O. The mentioned complex is
decomposed in four steps. The ﬁrst and second steps are occur-
ring at 50–135 C and corresponding to the evolution of
2(H2O) molecules, representing a weight loss of 6.80% and
its calculated value is 7.07%. While, the last two decomposi-
tion steps are occurring at 135–490 C and corresponding tond thermal degradation behavior of Mg(II), Ca(II), Ba(II) and
mistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.08.017
Figure 12 TG/DTG curve of Ca(II) complex of paracetamol.
Figure 13 TG/DTG curve of Ba(II) complex of paracetamol.
Figure 14 TG/DTG curve of Sr(II) complex of paracetamol.
10 M.S. Refat et al.the loss of 2(OH), C6H6, 2(CO), C6H6O and 2(NH3) mole-
cules, representing a weight loss of 58.62% and its calculated
value is 58.12%. The ﬁnal products resulting at 800 C contain
BaO polluted with two carbon atoms.Please cite this article in press as: Refat, M.S. et al., Spectroscopic a
Sr(II) complexes with paracetamol drug. Arabian Journal of Che3.1.5.4. [Sr(para)2(OH)2]Æ2H2O. The thermal decomposition
of [Sr(para)2(OH)2]Æ2H2O complex occurs at six steps. The
ﬁrst, second and third decomposition steps take place in the
range of 35–175 C and correspond to the elimination ofnd thermal degradation behavior of Mg(II), Ca(II), Ba(II) and
mistry (2013), http://dx.doi.org/10.1016/j.arabjc.2013.08.017
Table 5 Antimicrobial data of paracetamol complexes.
Complexes Diameter of inhibition zone (cm)
Bacillus subtilis Bacillus cereus E. coli Pseudomonas aeruginosa A. niger A. ﬂavus
Control 0 0 0 0 0 0
[Mg(para)2(OH)2]Æ2H2O 0 0 0.3 0 0.5 0.3
[Ca(para)2(OH)2]Æ6H2O 0 0 0.4 0 1.5 0.2
[Ba(para)2(OH)2]Æ2H2O 0 0 0.5 0 1.3 0.4
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Figure 16 Structure of paracetamol complexes, where
[M=Mg(II), Ca(II), Ba(II) and Sr(II)].
Spectroscopic and thermal degradation behavior of Mg(II), Ca(II), Ba(II) and Sr(II) complexes 112(H2O) molecules with an observed weight loss of 8.31%
(calcd. = 7.83%). The fourth step falls in the range of 175–
300 C which is assigned to the loss of 2(H2O), C6H6O,
C2H2 and 2(CO) molecules with a weight loss of
(obs. = 45.68%, calcd. = 46.13%). The last two decomposi-
tion steps are occurring at 300–605 C and corresponding to
the evolution of 2(NH3) and H2 gases, representing a weight
loss of 7.62% and its calculated value is 7.83%. The SrO
and 6C are the ﬁnal products remaining stable till 800 C.
3.1.6. Microbiological investigation of the paracetamol
complexes
Antibacterial and antifungal activities of paracetamol com-
plexes are carried out against the (Gram ve) as E. coli and
P. aeruginosa, (Gram +ve) as B. subtilis and B. cereus and
antifungal (A. niger and A. ﬂavus). The antimicrobial activity
was estimated based on the size of inhibition zone around
dishes. The M(II) complexes are found to have high activity
against bacteria especially E. coli and two kinds of fungi,
where as the Ca(II) complex is more active than the Ba(II),
Sr(II) and Mg(II) complexes, respectively against A. niger.
The data are listed in Table 5 and shown in Fig. 15.
3.1.7. Structure of the paracetamol complexes
The structures of the complexes of paracetamol with alkaline
earth metals such as Mg(II), Ca(II), Ba(II) and Sr(II) ions have
been conﬁrmed form the elemental analyses, IR, molar con-
ductance, UV–Vis, 1H NMR and thermal analysis data. Thus,Please cite this article in press as: Refat, M.S. et al., Spectroscopic a
Sr(II) complexes with paracetamol drug. Arabian Journal of Chefrom the IR spectra, it is concluded that paracetamol behaves
as a neutral bidentate ligand coordinated to the metal ions via
the lone pair of electrons of nitrogen and carbonyl O atoms of
the amide group. From the molar conductance data, it is found
that the complexes seem to be non-electrolytes. On the basis of
the above observations, octahedral geometries are suggested
for the investigated complexes. As a general conclusion, the
investigated complex structures can be given as shown in
Fig. 16.
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